Skip to content

Author

Devananda Devegowda

We have 3 of 76 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023.

The findings highlight the need for targeted strategies to improve early diagnosis and reduce the burden of myocarditis, particularly in vulnerable populations and lower-resource settings, while being interpreted in the context of evolving diagnostic and coding practices.

Sooji Lee, Hayeon Lee, Min Seo Kim et al. · 1 citation
Open access Sep 2026

Phenotypic characterization of biofilm and multidrug resistance among clinical isolates of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital

Background: Acinetobacter baumannii ( A. baumannii ) is a gram-negative, opportunistic bacterium. And it is one of the primary cause of infections associated with healthcare, particularly in intensive care units. Its capacity to build biofilm and acquire multidrug resistance, which increases its virulence and persisten...

Akshaya Paramasivam, Tejashree Anantharaj Urs, Satyasai Badveti et al. · 0 citations
Open access Aug 2026

7-Deshydroxypyrogallin-4-carboxylic acid dietary phytochemical as a putative FTO inhibitor in breast cancer: an integrated computational and cytotoxicity study.

These findings provide a preliminary mechanistic and experimental framework for DCA as a dietary FTO inhibitor in breast cancer, necessitating further validation through orthogonal target engagement assays, m6A quantification, and in vivo tumor models.

Shuaib Pasha, S. Harishkumar, Revanth Handralu Chandraiah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.